Change search criteria ↓

Search results

45 projects found matching your search criteria:

  1. 1. Glaucoma neuroprotection with BDNF on the level of retinal and primary visual cortex

    Principal investigator: Anna Wójcik- Gryciuk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: PRELUDIUM 12, Panel: NZ7

  2. 2. GLP-1R activation as an approach to modulate the effects of HHV-1 on neuronal functions – studies in mouse astrocytes

    Principal investigator: Adrianna Niedzielska

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

    Call: PRELUDIUM 24, Panel: NZ5

  3. 3. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh…

    Principal investigator: Katarzyna Aleksandra Szafrańska

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  4. 4. Astrocytic contributions to endogenous neuroprotection: Can astrocytes point the way to neuroprotective treatments?

    Principal investigator: dr hab. Małgorzata Beręsewicz-Haller

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 29, Panel: NZ5

  5. 5. Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ7

  6. 6. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect…

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 26, Panel: NZ7

  7. 7. Impact of Lactic Acid Fermentation on Sour Cherry (Prunus cerasus L.) Juice: Flavonols Composition and Health Implicatio…

    Principal investigator: dr Kamila Borowiec

    Uniwersytet Przyrodniczy w Lublinie, Wydział Nauk o Żywności i Biotechnologii

    Call: SONATA 19, Panel: NZ9

  8. 8. The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain…

    Principal investigator: dr Bartosz Sebastian Pomierny

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA BIS 13, Panel: NZ7

  9. 9. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b…

    Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 22, Panel: NZ7

  10. 10. Evaluation of immunomodulatory and neuroregenerative capacity of glial cell derived from human mesenchymal stem cells of…

    Principal investigator: dr hab. Joanna Beata Sypecka

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM BIS 4, Panel: NZ4

  11. 11. Neuroprotective properties of β-cyclodextrin-1,2,4-triazole inclusion complexes

    Principal investigator: prof. Tomasz Sylwester Plech

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM BIS 4, Panel: NZ7

  12. 12. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 21, Panel: NZ7

  13. 13. The role of Brain Derived Neurotrophic Factor (BDNF) and electrical synapses in the neuroprotective activity of Escitalo…

    Principal investigator: dr hab. Adrian Smędowski

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: PRELUDIUM BIS 3, Panel: NZ5

  14. 14. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of …

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  15. 15. Multifunctional plant systems as a complex way of providing neuroprotective activity

    Principal investigator: dr Anna Stasiłowicz-Krzemień

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: PRELUDIUM 20, Panel: NZ7

  16. 16. Interaction between selective estrogen receptor modulators (SERMs) and FasR/FasL pathway in the retina of ovariectomized…

    Principal investigator: Piotr Paweł Rodak

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: PRELUDIUM 20, Panel: NZ4

  17. 17. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 20, Panel: NZ7

  18. 18. New approach for neuronal regeneration and survival following ischemic stroke - gene therapy based on MEF2A repression u…

    Principal investigator: dr Malwina Anna Lisek

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: SONATA 16, Panel: NZ4

  19. 19. Novel role of peroxisome proliferator-activated receptor α in the regulationof amyloid β peptide metabolism and mitochon…

    Principal investigator: dr Sylwia Żulińska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 18, Panel: NZ4

  20. 20. Strategies to protect against methamphetamine-induced neurotoxicity

    Principal investigator: prof. Michał Jan Toborek

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach, Instytut Fizjoterapii i Nauk o Zdrowiu

    Call: OPUS 18, Panel: NZ7

  21. 21. Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng…

    Principal investigator: Justyna Beata Barut

    Instytut Farmakologii PAN

    Call: PRELUDIUM 18, Panel: NZ7

  22. 22. Molecular evaluation of the neuroprotective and regenerative properties of WJ-MSCs after transplantation into injured ra…

    Principal investigator: dr Wioletta Lech

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 18, Panel: NZ5

  23. 23. Searching for the background underlying the neuroprotective effects of the specific agonist of Y2 receptors - NPY(13-36)…

    Principal investigator: Łukasz Przykaza

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 17, Panel: NZ4

  24. 24. Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur…

    Principal investigator: Marcin Józef Drop

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 17, Panel: NZ7

  25. 25. Searching for effective strategies to protect neuronal cells against hypoxia and ischemia: Identification of neuroprotec…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ7

  26. 26. How microglia-astrocyte interaction affects neuronal functioning in the dopaminergic system. Analysis of the protective …

    Principal investigator: dr Katarzyna Zofia Kuter

    Instytut Farmakologii PAN

    Call: OPUS 14, Panel: NZ7

  27. 27. Expression of microRNA and its effect on the level of proteins with neuroprotective properties in the pathogenesis of th…

    Principal investigator: prof. Ireneusz Jacek Majsterek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski; Oddział Lekarski

    Call: OPUS 14, Panel: NZ7

  28. 28. Development of the novel experimental gene therapy approach for glaucoma treatment - focusing on the role of RNA-binding…

    Principal investigator: dr Adrian Smędowski

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: SONATA 13, Panel: NZ4

  29. 29. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc…

    Principal investigator: Michał Karol Załuski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 12, Panel: NZ7

  30. 30. The influence of a new hybryd compound derived from 2-(2,5-dioxopyrrolidin-1-yl) propanamide on hippocampal neuroprotect…

    Principal investigator: dr hab. Marta Andres-Mach

    Instytut Medycyny Wsi im. Witolda Chodźki

    Call: OPUS 10, Panel: NZ7

  31. 31. Identification and functional analysis of factors secreted by oligodendrocyte progenitors in response to rat CNS injury …

    Principal investigator: dr hab. Joanna Beata Sypecka

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 8, Panel: NZ4

  32. 32. The role of ceramide and sphingosine-1-phosphate receptor signalling in amyloid beta precursor protein metabolism.

    Principal investigator: dr Kinga Sylwia Czubowicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 6, Panel: NZ4

  33. 33. The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t…

    Principal investigator: Joanna Agata Motyl

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 5, Panel: NZ4

  34. 34. The role of poly(ADP-ribose) polymerase and sirtuins in molecular mechanism of cell death. Identification of novel targe…

    Principal investigator: prof. Joanna Benigna Strosznajder

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 5, Panel: NZ3

  35. 35. In vivo magnetic resonance evaluation of the progression of extra-retinal neurodegeneration in DBA/2J mouse model of spo…

    Principal investigator: dr Michał Marcin Fiedorowicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA 4, Panel: NZ4

  36. 36. The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m…

    Principal investigator: dr Agnieszka Wąsik

    Instytut Farmakologii PAN

    Call: OPUS 4, Panel: NZ7

  37. 37. Investigation of neuroprotective potency and mechanism of action of opioid-neurotensin hybrid peptides in organotypic hi…

    Principal investigator: dr Patrycja Magdalena Kleczkowska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 2, Panel: NZ4

  38. 38. The role of GPR39 receptor in the mechanism of antidepressant action

    Principal investigator: dr Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 2, Panel: NZ7

  39. 39. Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege…

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

    Call: OPUS 2, Panel: NZ7

  40. 40. Neuroprotective properties of biphalin in a mouse model of mild traumatic brain injury

    Principal investigator: dr Anna Agata Leśniak

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 2, Panel: NZ4

  41. 41. Synthesis of biocompatible nanocarriers for selected neuroprotective agents

    Principal investigator: Marek Piotrowski

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

    Call: PRELUDIUM 2, Panel: ST5

  42. 42. Impact of selective modulators of estrogen and aryl hydrocarbon receptors on hypoxia/ischemia-induced neuronal cell dama…

    Principal investigator: Joanna Rzemieniec

    Instytut Farmakologii PAN

    Call: PRELUDIUM 1, Panel: NZ3

  43. 43. A comparison of neuroprotective features of human mesenchymal stem cells (MSC) derived from adult (bon marrow) and neona…

    Principal investigator: prof. Krystyna Antonina Domańska-Janik

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 1, Panel: NZ3

  44. 44. Biomarkers of neurodegeneration and endogenous neuroprotection in epilepsy

    Principal investigator: prof. Konrad Rejdak

    Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

    Call: HARMONIA 1, Panel: NZ4

  45. 45. Evaluation of the protective capacity of resveratrol and quercetin in models of neurotoxicity induced by aluminum and ma…

    Principal investigator: dr Maciej Tadeusz Gawlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

Graphic design and implementation: Jakub Piotrowski